FDA Policy Roadmap Targets Opioid Addiction, Strengthening Generic Competition

Drug Industry Daily
A A
The FDA will prioritize the opioid crisis, innovation, and generic competition in the coming year, the agency said in a 2018 Strategic Policy Roadmap released Thursday.

To View This Article:

Login

Subscribe To Drug Industry Daily